• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form RW filed by Atlantic International Corp.

    7/14/25 4:05:04 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    RW 1 ea0248844-rw_atlantic.htm WITHDRAWAL REQUEST

    ATLANTIC INTERNATIONAL CORP.

    270 Sylvan Avenue, Suite 2230

    Englewood Cliffs, New Jersey 07632

     

    July 14, 2025

     

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street NE

    Washington, D.C. 20549-3628

     

    Re:Atlantic International Corp. Registration Statement on Form S-4

    File No. 333-284049

     

    Dear Ladies and Gentlemen:

     

    Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”) Atlantic International Corp (the “Company”) hereby applies for withdrawal if its Registration Statement on Form S-4 last filed by the Securities and Exchange Commission (the “SEC”) on January 24, 2025 (File No. 333-284049) (the “Registration Statement”). The Company is withdrawing the Registration and none of the 2,108,188 shares of Common Stock registered under the Registration Statement have been sold in connection with this offering. The transaction was terminated. This letter confirms that, pursuant to Rule 477 under the Securities Act, the Registration Statement is hereby withdrawn.

     

    Please contact the undersigned at (201) 739-7955 if you have any questions regarding this matter.

     

      Sincerely,
       
      /s/ Jeffrey Jagid  
      Jeffrey Jagid
      Chief Executive Officer

     

    EHL:esm

     

    Get the next $ATLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atlantic International Corp. Postpones Annual General Meeting

      ENGLEWOOD CLIFFS, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has postponed its Annual General Meeting, originally scheduled for July 15, 2025, has been postponed until a date to be determined later this year. About Atlantic International Corp. Atlantic International Corp. (NASDAQ:ATLN) is a publicly traded global platform of outsourced services and workforce solutions. Through its subsidiaries, including Lyneer Staffing Solutions, Atlantic provides tailored staffing, recruiting, and strategic outsourcing solutions across a wide range

      7/18/25 5:30:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. Added to Membership of Russell 3000® Index

      ENGLEWOOD CLIFFS, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that it has been added as a member of the broad-market Russell 3000® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes annual reconstitution. The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, results in automatic inclusion in either the large-cap Russell 100

      6/17/25 9:01:17 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Lyneer Staffing Solutions Integrates Advanced AI Capabilities into Proprietary Ecosystem, Advancing Data-Driven Workforce Solutions

      ENGLEWOOD CLIFFS, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services, and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has successfully integrated cutting-edge artificial intelligence capabilities into its proprietary Apollo Ecosystem. This strategic enhancement positions Lyneer at the forefront of the staffing industry's digital transformation while maintaining its commitment to human-centered service delivery. The AI-powered Apollo Ecosystem now leverages advanced machine learning algorithms and predictive analytics to deliver unp

      6/5/25 12:00:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    SEC Filings

    See more
    • SEC Form RW filed by Atlantic International Corp.

      RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/14/25 4:05:04 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 424B3 filed by Atlantic International Corp.

      424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/8/25 4:31:45 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form EFFECT filed by Atlantic International Corp.

      EFFECT - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      7/7/25 12:15:24 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:11:34 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:04:40 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

      4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      6/25/25 5:02:59 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

      ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

      6/2/25 1:05:49 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Financials

    Live finance-specific insights

    See more
    • Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

      Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

      3/28/25 7:30:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials